Previous 10 | Next 10 |
ViewRay (NASDAQ: VRAY ) Q4 results : More news on: ViewRay, Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, , Read more ...
CLEVELAND , March 12, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2019 . A supplemental presentation for today's conference call is included on the Company's website at http://investors....
CLEVELAND , Feb. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, March 12, 2020 at 4:30 p....
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 01/27/2020. Please visit our Tracking Kahn Brothers Portfolio series t...
ViewRay ( VRAY ) is the developer of the MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. This is a promising technology, but ViewRay isn't the only one offering it. Sweden's Elekta is offering the Unity, which is a comparable device ...
Gainers: Adaptimmune Therapeutics (NASDAQ: ADAP ) +242% . More news on: Adaptimmune Therapeutics plc, Aethlon Medical, Inc., BioCardia, Inc., Stocks on the move, Read more ...
Investors in ViewRay (NASDAQ: VRAY) , a healthcare company focused on next-generation radiation therapy machines, are having a rough day. Shares are down 21% as of 12:08 p.m. EST on Monday after management reported preliminary fourth-quarter and full-year results that missed the mark. Here a...
ViewRay (NASDAQ: VRAY ) announced preliminary Q4 and FY2019 results. More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Read more ...
CLEVELAND , Jan. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2019 . The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full...
Small-cap rad-onc company ViewRay ( VRAY ) certainly doesn't lack for ambition, as it is trying to disrupt the $5 billion radiation oncology equipment market with its MRI-guided MRIdian system. While ViewRay brings a lot of positives to the table that should presage meaningful market growth,...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...